We are live on ! Find out more
XGN icon

Exagen
XGN

57 hedge funds and large institutions have $156M invested in Exagen in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 3

162% more capital invested

Capital invested by funds: $59.8M → $156M (+$96.5M)

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

63% more funds holding

Funds holding: 35 → 57 (+22)

19.19% more ownership

Funds ownership: 35.46% → 54.65% (+19%)

Holders
57
Holders Change
+22
Holders Change %
+62.86%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
17
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$11.5M
2
PIM
Platinum Investment Management
Australia
+$7.13M
3
RI
RTW Investments
New York
+$6.7M
4
NCM
Nantahala Capital Management
Connecticut
+$6.67M
5
PVI
Pura Vida Investments
New York
+$5.9M

Top Sellers

Rank Fund Capital Flow
1
HP
Harbourvest Partners
Massachusetts
-$343K
2
Brown Advisory
Brown Advisory
Maryland
-$229K
3
Squarepoint
Squarepoint
New York
-$133K
4
Wells Fargo
Wells Fargo
California
-$100K
5
Northern Trust
Northern Trust
Illinois
-$64.6K

XGN Hedge Fund Activity: Q1 2021 in Review

57 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q1 2021, worth a combined $156M — up 162% from $59.8M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new XGN positions and 3 closed out — a net gain of 22 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $11.5M. The largest seller was Harbourvest Partners, exiting entirely with an estimated $343K sold.

  • 57 institutional investors held Exagen (XGN) as of Q1 2021, up from 35 in Q4 2020.
  • Funds reported $156M of Exagen stock for Q1 2021, up 162% quarter-over-quarter.
  • 25 funds opened new Exagen positions in Q1 2021 and 3 closed out, a net change of +22 holders.
  • The largest Exagen buyer in Q1 2021 was Wasatch Advisors, an estimated $11.5M added.
  • The largest Exagen seller in Q1 2021 was Harbourvest Partners, an estimated $343K sold.

Based on aggregated 13F filings for Q1 2021.